Ono Pharmaceuticals
Executive Summary
Osaka, Japan-based company opened first U.S. base of operations in October in Seattle under the managing directorship of Tsuenhiro Komatsabura. Ono already holds a significant equity investment in and supplies research funds to San Diego-based Telios Pharmaceuticals.